Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Krawczyk, Janusz  [Clear All Filters]
Journal Article
Baev DV, Krawczyk J, O׳Dwyer M, Szegezdi E. The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells. Leuk Res Rep. 2014;3(2):79-82.
Ding Y, Carvalho E, Murphy C, McInerney V, Krawczyk J, O'Brien T, Howard L, Cai L, Shen S. Corrigendum to "Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)" [Stem Cell Res. (43) 2020 101665]. Stem Cell Res. 2022;63:102850.
Ding Y, de la Cruz BMarcó, Xia Y, Liu M, Lu Y, McInerney V, Krawczyk J, Lynch SA, Howard L, O'Brien T, et al. Derivation of familial iPSC lines from three ASD patients carrying NRXN1α and two controls (NUIGi022-A, NUIGi022-B; NUIGi023-A, NUIGi023-B; NUIGi025-A, NUIGi025-B; NUIGi024-A, NUIGi024-B; NUIGi026-A, NUIGi026-B). Stem Cell Res. 2019;41:101653.
Ding Y, Carvalho E, Murphy C, McInerney V, Krawczyk J, O'Brien T, Howard L, Cai L, Shen S. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A). Stem Cell Res. 2019;43:101665.
Ding Y, O'Brien A, de la Cruz BMarcó, Yang M, Lu Y, Qian X, Yang G, McInerney V, Krawczyk J, Lynch SA, et al. Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B). Stem Cell Res. 2021;53:102254.
Ding Y, O'Brien A, de la Cruz BMarcó, Yang M, Fitzgerald J, Yang G, Li W, McInerney V, Krawczyk J, Lynch SA, et al. Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B). Stem Cell Res. 2021;52:102222.
de la Cruz BMarcó, Ding Y, McInerney V, Krawczyk J, Lu Y, Yang G, Qian X, Li W, Howard L, Allen NM, et al. Derivation of two iPSC lines from a sporadic ASD patient (NUIGi033-A) and a paternal control (NUIGi034-A). Stem Cell Res. 2020;44:101722.
Ge N, Liu M, Krawczyk J, McInerney V, Ward D, Shen S, O'Brien T, Prendiville T. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant. Stem Cell Res. 2020;49:101997.
Liu M, Ge N, Han Y, Reilly J, Yang M, Yang F, Krawczyk J, McInerney V, O'Brien T, Prendiville T, et al. Generation and characterization of three induced pluripotent stem cell lines (NUIGi046-A, NUIGi046-B, NUIGi046-C) from a 51-year-old healthy individual. Stem Cell Res. 2021;57:102607.
Ge N, Liu M, Ding Y, Krawczyk J, McInerney V, Galvin J, Shen S, Prendiville T, O'Brien T. Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation. Stem Cell Res. 2019;41:101650.
Ge N, Liu M, Zhu X, Krawczyk J, McInerney V, Shen S, O'Brien T, Prendiville T. Generation and characterization of two induced pluripotent stem cell lines (NUIGi038-A, NUIGi038-B) from dermal fibroblasts of a healthy individual. Stem Cell Res. 2020;49:101996.
Ge N, Liu M, Krawczyk J, McInerney V, Galvin J, Shen S, O'Brien T, Prendiville T. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-. Stem Cell Res. 2019;39:101502.
Stewart R, Gadoud C, Krawczyk J, McInerney V, O'Brien T, Shen S, Allen NM. Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.881C > T; p.Ala294Val (NUIGi059-A, NUIGi059-B, NUIGi059-C) and 3 healthy controls (NUIGi. Stem Cell Res. 2023;71:103191.
Stewart R, Gadoud C, Krawczyk J, McInerney V, O'Brien T, Shen S, Allen NM. Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.638C > T; p.Arg213Gln (NUIGi063-A, NUIGi063-B, NUIGi063-C) and 3 healthy controls (NUIGi. Stem Cell Res. 2023;69:103093.
Avazzadeh S, McDonagh K, Reilly J, Wang Y, Boomkamp SD, McInerney V, Krawczyk J, Fitzgerald J, Feerick N, O'Sullivan M, et al. Increased Ca signaling in neurons derived from ASD induced pluripotent stem cells. Mol Autism. 2019;10:52.